128 related articles for article (PubMed ID: 9990656)
1. Effects of different antisecretory drugs on gastric potential difference in the rat: comparison with sucralfate.
Coruzzi G; Coppelli G; Frati P; Bertaccini G
Pharmacol Res; 1998 Dec; 38(6):469-73. PubMed ID: 9990656
[TBL] [Abstract][Full Text] [Related]
2. The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion.
Blum RA; Shi H; Karol MD; Greski-Rose PA; Hunt RH
Clin Ther; 1997; 19(5):1013-23. PubMed ID: 9385488
[TBL] [Abstract][Full Text] [Related]
3. Gastric transmucosal potential difference: effect of antisecretory and gastroprotective drugs.
Nosál'ová V; Babul'ová A; Bauer V
Gen Pharmacol; 1998 Mar; 30(3):325-9. PubMed ID: 9510081
[TBL] [Abstract][Full Text] [Related]
4. Effects of sucralfate, lansoprazole, and cimetidine on the delayed healing by hydrocortisone sodium phosphate of chronic gastric ulcers in the rat.
Kuwayama H; Matsuo Y; Eastwood GL
Am J Med; 1991 Aug; 91(2A):15S-19S. PubMed ID: 1882902
[TBL] [Abstract][Full Text] [Related]
5. In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity.
Arnestad JS; Kleveland PM; Waldum HL
Aliment Pharmacol Ther; 1997 Apr; 11(2):355-8. PubMed ID: 9146775
[TBL] [Abstract][Full Text] [Related]
6. Gastric antisecretory activity of lansoprazole in different experimental models: comparison with omeprazole.
Coruzzi G; Adami M; Bertaccini G
Gen Pharmacol; 1995 Sep; 26(5):1027-32. PubMed ID: 7557245
[TBL] [Abstract][Full Text] [Related]
7. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
Kinoshita M; Saito N; Tamaki H
Eur J Pharmacol; 1997 Mar; 321(3):325-32. PubMed ID: 9085044
[TBL] [Abstract][Full Text] [Related]
8. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate.
Slomiany BL; Piotrowski J; Slomiany A
J Physiol Pharmacol; 2000 Jun; 51(2):179-92. PubMed ID: 10898092
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the protective effect of lansoprazole on human gastric mucosa against low-dose acetylsalicylic acid. An endoscopic controlled double-blind study].
Müller P; Fuchs W; Simon B
Arzneimittelforschung; 1997 Jun; 47(6):758-60. PubMed ID: 9281302
[TBL] [Abstract][Full Text] [Related]
11. A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion. Prophylactic effects of antiulcer drugs.
Takayama S; Izuhara C; Yamada N; Yamanaka S; Hashimoto E; Kaneko S; Takeuchi K
J Physiol Pharmacol; 2012 Feb; 63(1):41-52. PubMed ID: 22460460
[TBL] [Abstract][Full Text] [Related]
12. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of sucralfate and omeprazole on gastric mucosal damage induced by ethanol in rats.
Kaya N; Boyunapa H; Baris S; Kahraman H; Altintop L
Wien Klin Wochenschr; 1998 Feb; 110(3):96-100. PubMed ID: 9553204
[TBL] [Abstract][Full Text] [Related]
14. A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.
Hori Y; Matsukawa J; Takeuchi T; Nishida H; Kajino M; Inatomi N
J Pharmacol Exp Ther; 2011 Jun; 337(3):797-804. PubMed ID: 21411494
[TBL] [Abstract][Full Text] [Related]
15. Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury.
Blandizzi C; Natale G; Gherardi G; Lazzeri G; Marveggio C; Colucci R; Carignani D; Del Tacca M
Dig Dis Sci; 1999 Oct; 44(10):2039-50. PubMed ID: 10548356
[TBL] [Abstract][Full Text] [Related]
16. Lansoprazole: a comprehensive review.
Zimmermann AE; Katona BG
Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
[TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.
Katashima M; Yamamoto K; Sugiura M; Sawada Y; Iga T
Drug Metab Dispos; 1995 Jul; 23(7):718-23. PubMed ID: 7587960
[TBL] [Abstract][Full Text] [Related]
18. Lansoprazole and ethanol metabolism: comparison with omeprazole and cimetidine.
Battiston L; Tulissi P; Moretti M; Pozzato G
Pharmacol Toxicol; 1997 Dec; 81(6):247-52. PubMed ID: 9444664
[TBL] [Abstract][Full Text] [Related]
19. Effect of omeprazole, lansoprazole, and ranitidine on the DNA synthesis of mononuclear cells.
Peddicord TE; Olsen KM; Collier DS
Crit Care Med; 1999 Jan; 27(1):90-4. PubMed ID: 9934899
[TBL] [Abstract][Full Text] [Related]
20. [Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion].
Inatomi N; Murakami I; Asano S; Inada I; Satoh H
Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):333-43. PubMed ID: 9017687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
